Anti-™127/ ™EM127 monoclonal antibody

Anti-™127/ ™EM127 antibody for FACS & in-vivo assay

Target products collectionGo to ™EM127/™EM127 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1818-Ab-1/ GM-Tg-hg-MP1818-Ab-2Anti-Human ™EM127 monoclonal antibodyHuman
GM-Tg-rg-MP1818-Ab-1/ GM-Tg-rg-MP1818-Ab-2Anti-Rat ™EM127 monoclonal antibodyRat
GM-Tg-mg-MP1818-Ab-1/ GM-Tg-mg-MP1818-Ab-2Anti-Mouse ™EM127 monoclonal antibodyMouse
GM-Tg-cynog-MP1818-Ab-1/ GM-Tg-cynog-MP1818-Ab-2Anti-Cynomolgus/ Rhesus macaque ™EM127 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1818-Ab-1/ GM-Tg-felg-MP1818-Ab-2Anti-Feline ™EM127 monoclonal antibodyFeline
GM-Tg-cang-MP1818-Ab-1/ GM-Tg-cang-MP1818-Ab-2Anti-Canine ™EM127 monoclonal antibodyCanine
GM-Tg-bovg-MP1818-Ab-1/ GM-Tg-bovg-MP1818-Ab-2Anti-Bovine ™EM127 monoclonal antibodyBovine
GM-Tg-equg-MP1818-Ab-1/ GM-Tg-equg-MP1818-Ab-2Anti-Equine ™EM127 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1818-Ab-1/ GM-Tg-hg-MP1818-Ab-2; GM-Tg-rg-MP1818-Ab-1/ GM-Tg-rg-MP1818-Ab-2;
GM-Tg-mg-MP1818-Ab-1/ GM-Tg-mg-MP1818-Ab-2; GM-Tg-cynog-MP1818-Ab-1/ GM-Tg-cynog-MP1818-Ab-2;
GM-Tg-felg-MP1818-Ab-1/ GM-Tg-felg-MP1818-Ab-2; GM-Tg-cang-MP1818-Ab-1/ GM-Tg-cang-MP1818-Ab-2;
GM-Tg-bovg-MP1818-Ab-1/ GM-Tg-bovg-MP1818-Ab-2; GM-Tg-equg-MP1818-Ab-1/ GM-Tg-equg-MP1818-Ab-2
Products NameAnti-™EM127 monoclonal antibody
Formatmab
Target Name™EM127
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-™EM127 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species ™127/ ™EM127 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP000811human ™EM127 Lentivirus particle
    ORF Viral VectorpGMLP000811human ™EM127 Lentivirus plasmid
    ORF Viral VectorpGMLPm002253mouse Tmem127 Lentivirus plasmid
    ORF Viral VectorvGMLPm002253mouse Tmem127 Lentivirus particle


    Target information

    Target IDGM-MP1818
    Target Name™EM127
    Gene ID55654,69470,311405,705069,609057,101091188,513620,100062454
    Gene Symbol and Synonyms2310003P10Rik,RGD1309744,™EM127
    Uniprot AccessionO75204
    Uniprot Entry Name™127_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000135956
    Target ClassificationN/A

    The target: ™EM127, gene name: ™EM127, also named as . This gene encodes a transmembrane protein with 3 predicted transmembrane domains. The protein is associated with a subpopulation of vesicular organelles corresponding to early endosomal structures, with the Golgi, and with lysosomes, and may participate in protein trafficking between these structures. Mutations in this gene and several other genes cause pheochromocytomas. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Aug 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.